Corerx, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 14205 Myerlake Circle, Clearwater, Florida (FL) 33760, United States (USA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3007209985 · DUNS 780516717
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-02-26
- NAIDrug Quality Assurance2021-08-13
- VAIDrug Quality Assurance2020-03-06
- VAIDrug Quality Assurance2017-09-27
- VAIDrug Quality Assurance2015-06-19
Drugs this plant is listed as making
6 distinct drugs across 6 products name this site in their FDA label.
- Aminocaproic acidBpi Labs Llc
- AtovaquoneBionpharma Inc.
- ClobazamBionpharma Inc.
- Eflornithine HydrochlorideUswm, Llc
- Enalapril maleateBionpharma Inc.
- RufinamideBionpharma Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.